PMDA drug package insert
センブリ・重曹散「ヨシダ」
PMDA Prescription drug · 吉田製薬株式会社 · package insert Nov 8, 2023
Key facts
| Brand names | センブリ・重曹散「ヨシダ」 |
|---|---|
| Nonproprietary names | センブリ・重曹 |
| Companies | 製造販売元／吉田製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 苦味健胃剤 |
| Therapeutic category codes | 872333 |
| YJ codes | 2339106B1194 |
| Approval numbers | 16100AMZ01772000 |
| Package insert edition | 第1版 |
| Package insert date | Nov 8, 2023 |
| PMDA document key | 830039_2339106B1194_1 |
| PMDA company code | 830039 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: